Header cover image

South Korean (KOSPI) Pharma Industry Analysis

UpdatedFeb 05, 2023
DataAggregated Company Financials
Companies100
  • 7D1.9%
  • 3M8.8%
  • 1Y-13.9%
  • YTD1.8%

Over the last 7 days, the Pharma industry has risen 2.5%, driven by gains from Caregen of 37%. During this same period, the SK Biopharmaceuticals underperformed, falling 5.1%. In contrast, the industry has lost 14% in the last 12 months. Looking forward, earnings are forecast to grow by 32% annually.

Industry Valuation and Performance

Has the South Korean Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 05 Feb 2023₩46.4t₩27.7t₩743.5b20.4x62.4x1.7x
Tue, 03 Jan 2023₩45.6t₩28.0t₩770.2b20x59.2x1.6x
Thu, 01 Dec 2022₩45.0t₩28.0t₩767.8b19x58.5x1.6x
Sat, 29 Oct 2022₩42.2t₩27.2t₩694.8b20.5x60.8x1.5x
Mon, 26 Sep 2022₩42.7t₩27.5t₩720.9b20.1x59.3x1.6x
Wed, 24 Aug 2022₩48.5t₩26.8t₩469.4b21.5x103.4x1.8x
Fri, 22 Jul 2022₩51.3t₩26.7t₩475.9b22.8x107.9x1.9x
Sun, 19 Jun 2022₩47.2t₩26.7t₩475.9b21.2x99.2x1.8x
Tue, 17 May 2022₩52.7t₩26.1t₩670.0b25.3x78.6x2x
Thu, 14 Apr 2022₩55.8t₩26.1t₩674.3b26.4x82.7x2.1x
Sat, 12 Mar 2022₩55.9t₩25.0t₩927.2b23.7x60.3x2.2x
Mon, 07 Feb 2022₩53.0t₩25.0t₩934.5b21.8x56.7x2.1x
Wed, 05 Jan 2022₩61.0t₩25.0t₩934.5b24.6x65.3x2.4x
Fri, 03 Dec 2021₩58.0t₩25.0t₩936.5b24.8x61.9x2.3x
Sun, 31 Oct 2021₩61.2t₩24.7t₩876.1b23.9x69.8x2.5x
Tue, 28 Sep 2021₩68.7t₩24.9t₩890.6b28x77.2x2.8x
Thu, 26 Aug 2021₩71.9t₩26.0t₩960.3b39.2x74.8x2.8x
Fri, 02 Jul 2021₩73.4t₩25.3t₩928.3b40.5x79.1x2.9x
Mon, 05 Apr 2021₩66.4t₩24.9t₩915.5b33x72.5x2.7x
Thu, 07 Jan 2021₩87.9t₩24.7t₩894.2b37.3x98.3x3.6x
Wed, 30 Sep 2020₩73.8t₩24.4t₩499.4b32.2x147.7x3x
Sat, 04 Jul 2020₩49.1t₩23.9t₩745.7b24.5x65.8x2.1x
Tue, 07 Apr 2020₩38.3t₩23.6t₩732.3b19.6x52.3x1.6x
Price to Earnings Ratio

56.8x


Total Market Cap: ₩35.3tTotal Earnings: ₩621.5bTotal Revenue: ₩23.1tTotal Market Cap vs Earnings and Revenue0%0%0%
South Korean Pharma Industry Price to Earnings3Y Average 82.9x202120222023
Current Industry PE
  • Investors are pessimistic on the South Korean Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 62.5x which is lower than its 3-year average PE of 82.9x.
  • The 3-year average PS ratio of 2.3x is higher than the industry's current PS ratio of 1.7x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 6.2% per year over the last three years.
  • Revenues for these companies have grown 6.3% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the South Korean Healthcare industry?

KR Market0.38%
Healthcare1.56%
Pharma1.92%
Pharma1.92%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
A214370 Caregen₩187.50k37.1%
+₩498.2b
198.1%PE71.6x
A000250 Sam Chun Dang Pharm₩51.10k10.1%
+₩103.7b
42.3%PS6.4x
A039200 Oscotec₩20.85k10.8%
+₩77.6b
-37.2%PS163.6x
A003520 Yungjin Pharm₩3.63k8.7%
+₩53.0b
-25.9%n/a
A069620 Daewoong pharmaceuticalLtd₩151.50k2.5%
+₩41.0b
10.2%PE20.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

A214370

₩187,500.00

Caregen

7D

37.1%

1Y

198.1%

A069620

₩151,500.00

Daewoong pharmaceuticalLtd

7D

2.5%

1Y

10.2%

A000640

₩99,300.00

Dong-A Socio Holdings

7D

-0.7%

1Y

-1.7%

A008930

₩31,050.00

Hanmi Science

7D

1.8%

1Y

-32.9%

A003850

₩9,700.00

Boryung

7D

-0.6%

1Y

-22.4%

A000100

₩53,300.00

Yuhan

7D

-1.5%

1Y

-3.8%

A002620

₩13,340.00

Jeil Pharma Holdings

7D

-1.9%

1Y

-0.8%

A002390

₩16,950.00

HANDOK

7D

-1.3%

1Y

-19.3%

A216080

₩15,540.00

JETEMA

7D

-1.0%

1Y

-14.1%

A140410

₩14,220.00

Mezzion PharmaLtd

7D

9.9%

1Y

-76.6%

A039200

₩20,850.00

Oscotec

7D

10.8%

1Y

-37.2%

A000250

₩51,100.00

Sam Chun Dang Pharm

7D

10.1%

1Y

42.3%

A003520

₩3,630.00

Yungjin Pharm

7D

8.7%

1Y

-25.9%

A019170

₩21,800.00

Shin Poong Pharm.Co.Ltd

7D

3.1%

1Y

-12.6%